<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="100809">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01888159</url>
  </required_header>
  <id_info>
    <org_study_id>SEvsTSinAMH</org_study_id>
    <nct_id>NCT01888159</nct_id>
  </id_info>
  <brief_title>Salpingectomy vs Tubal Sterilisation in Low Risk for Ovarian Cancer Women and Its Effect on Ovarian Reserve</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Karlstad Central Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Karlstad Central Hospital</source>
  <oversight_info>
    <authority>Sweden: Regional Ethical Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Randomised study to investigate if salpingectomies done to women wishing tubal sterilisation
      has an effect on ovarian reserve.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>September 2013</start_date>
  <primary_completion_date type="Anticipated">September 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention</study_design>
  <primary_outcome>
    <measure>Anti-Mullerian hormone (AMH)and Follicle Stimulation Hormone (FSH)</measure>
    <time_frame>3 months</time_frame>
    <safety_issue>Yes</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Anti-Mullerian hormone (AMH)</measure>
    <time_frame>1 year</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Operative time</measure>
    <time_frame>Postoperatively</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Complications</measure>
    <time_frame>3 months</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <other_outcome>
    <measure>Follicle Stimulation Hormone (FSH)</measure>
    <time_frame>3 months</time_frame>
    <safety_issue>Yes</safety_issue>
  </other_outcome>
  <other_outcome>
    <measure>Follicle Stimulation Hormone (FSH)</measure>
    <time_frame>1 year</time_frame>
    <safety_issue>Yes</safety_issue>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Ovarian Cancer</condition>
  <arm_group>
    <arm_group_label>Tubal Sterilization with bipolar</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Salpingectomy vs Tubal Sterilisation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Bilateral Salpingectomy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Salpingectomy vs Tubal Sterilisation</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Bilateral Salpingectomy</intervention_name>
    <arm_group_label>Bilateral Salpingectomy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Tubal sterilization with bipolar energy</intervention_name>
    <arm_group_label>Tubal Sterilization with bipolar</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Women seeking for tubal sterilisation

        Exclusion Criteria:

          -  women older than 45

          -  family history of ovarian cancer

          -  presence of menopausal symptoms

          -  irregular cycles

          -  Hormone Replacement Therapy or hormone contraceptions the last 3 months

          -  history of previous ovarian or uterine surgeries

          -  imaging suggesting an ovarian cyst or other adnexal pathology during investigation

          -  previous salpingectomy
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Leonidas Magarakis, MD</last_name>
    <phone>046737529929</phone>
    <email>lemagarakis@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Department of Obstetrics and Gynecology</name>
      <address>
        <city>Karlstad</city>
        <state>VÃ¤rmaland</state>
        <zip>65185</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>June 2013</verification_date>
  <lastchanged_date>June 25, 2013</lastchanged_date>
  <firstreceived_date>June 20, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Karlstad Central Hospital</investigator_affiliation>
    <investigator_full_name>Leonidas Magarakis</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>No</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Ovarian Neoplasms</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Disinfectants</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
